| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.9% | $333,364 | 280,138 | SABBY MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 6 institutional investors reported holding 227,043 shares of InMed Pharmaceuticals Inc. - Common Stock (INM). This represents 8% of the company’s total 2,829,677 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 227,043 | $240,666 | -$175,633 | $1.06 | 6 |
| 2025 Q3 | 303,584 | $665,240 | +$637,052 | $2.19 | 8 |
| 2025 Q2 | 8,470 | $28,508 | +$7,682 | $3.25 | 6 |
| 2025 Q1 | 6,408 | $13,264 | -$185,585 | $2.04 | 4 |
| 2024 Q4 | 48,870 | $226,645 | +$226,645 | $4.87 | 4 |